MOTS-c is one of six peptides that licensed U.S. compounding pharmacies can now prepare with a prescription, under a new interim federal policy. We're working to offer it through licensed U.S. providers. Join the waitlist to hear the day it's available, and what it costs.
We'll email you the day they launch. In the meantime, see what's available at Tides now.
MOTS-c
Each bead is one amino acid. Tap or hover for its name. Vial shown is an illustration.
MOTS-c is a 16-amino-acid peptide that's unusual for where it comes from. Almost all of your proteins are coded by DNA in the cell's nucleus. MOTS-c is coded by the small, separate genome inside your mitochondria, the parts of each cell that turn food into usable energy.
It was discovered in 2015 by researchers at the University of Southern California and belongs to a small family called mitochondrial-derived peptides. Your body makes it naturally and it travels in the blood, which is why scientists study it as a possible signal between mitochondria and the rest of the body.
MRWQEMGYIFYPRKLRMOTS-c has been studied in animal and early research for:
A rough picture of the published research on MOTS-c. Not a rating, and not a promise of results.
MOTS-c is not FDA-approved. In September 2023, FDA placed it on a list of substances that compounding pharmacies effectively couldn't use. On October 28, 2026, the U.S. Department of Health and Human Services announced an interim enforcement discretion policy covering MOTS-c and five other peptides.
In plain terms, federal regulators said they don't intend to take enforcement action against licensed 503A pharmacies that compound MOTS-c for an individual patient with a valid prescription, as long as the pharmacy meets strict conditions. It's a temporary policy, not an approval, and it could change.

Sept 2023
RestrictedFDA places the six peptides in Category 2, effectively blocking pharmacies from compounding them.
Apr 2026
Category 2 liftedThe peptides come off the restricted list, but that alone doesn't clear them for compounding.
Jul 2026
Advisory voteFDA's Pharmacy Compounding Advisory Committee votes to recommend them for the 503A bulks list.
Oct 28, 2026
Interim policyHHS announces it won't take enforcement action against licensed 503A pharmacies that compound them under set conditions.
Now
Tides waitlist openWe're lining up licensed pharmacies and provider guidelines. Waitlist members hear first.
The same way we offer NAD+, sermorelin and GLP-1s today: online, reviewed by a licensed provider, shipped to you.

Add your email. We'll write the day MOTS-c launches, with pricing.
From your phone. No clinic visit.
They review your health history and decide whether MOTS-c is appropriate for you.
If prescribed, a licensed 503A pharmacy prepares it for you and ships it to your door.
Pricing will be posted at launch.
MOTS-c is one of six peptides covered by the new policy. See all six, or pick one:
BPC-157A 15-amino-acid peptide studied in animal research on tendons, muscle and the gut.
TB-500A synthetic peptide based on thymosin beta-4, a protein almost every cell makes.
KPVThree amino acids from alpha-MSH, studied for inflammation in the gut and skin.
EpitalonA four-amino-acid peptide from Russian research on the pineal gland and aging.
SemaxA seven-amino-acid peptide developed in Russia, studied for attention and memory.One email the day it launches, with pricing. Pick any other peptides you're curious about, too.
Not yet available at Tides. Not FDA-approved. Prescription required. Nothing on this page is medical advice.
We'll email you the day they launch. In the meantime, see what's available at Tides now.
Not yet available at Tides. Not FDA-approved. Prescription required. Nothing on this page is medical advice.
This website is for informational and educational purposes only and does not constitute medical advice. Always consult a licensed healthcare provider before starting any treatment. Tides Health is a subscription platform. Fees apply for licensed provider consultations and medication fulfillment. Results and testimonials featured on this site reflect individual experiences and are not guaranteed to be typical. Individual results vary. Results may vary. Individual results depend on adherence to the program and licensed provider recommendations. Tides Health is a patient education platform. Clinical services are provided by licensed providers through our telehealth partner. Tides Health does not practice medicine. If you are experiencing a medical emergency, call 911 or go to your nearest emergency room immediately.